Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates
Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +25.93% and +4.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of +0.25% and +0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Can Volume Growth and RPT Recovery Support DaVita's Q2 Earnings?
DVA's Q2 results are likely to benefit from volume growth and RPT recovery, but payor mix pressure and spending on technology could limit margin gains.
Zacks
Are You Looking for a Top Momentum Pick? Why LifeStance Health Group (LFST) is a Great Choice
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
Beat the Market the Zacks Way: PDF Solutions, LifeStance Health, Paychex in Focus
Zacks highlights PDF Solutions, LifeStance Health and Paychex among stocks and portfolios that outperformed as markets weighed softer jobs data and earnings.
Zacks
Ensign Expands Texas Footprint With Two Skilled Nursing Acquisitions
ENSG expands its Texas footprint with two skilled nursing acquisitions, adding 250 licensed beds and strengthening its owned real estate portfolio.
Zacks
ELV Accelerates Clinical Reviews Through Health OS Platform
Elevance Health's Health OS is cutting review delays and admin work, with early results showing fewer denials and holds as digital healthcare adoption expands.
Zacks
Can Acadia's Turnaround Strategy Drive Long-Term Shareholder Value?
ACHC is shifting from expansion to returns, raising EBITDA guidance as mature facilities and rising demand support its turnaround strategy.
Zacks
LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare
Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare are benefiting from telehealth, AI adoption and growing home-care demand.
Zacks

Advertisement|Remove ads.